These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7983235)

  • 1. Controlled study with a new sustained-release formulation of nifedipine in essential hypertensive patients.
    Galletti F; Barba G; Nardecchia A; Strazzullo P; Scagliusi P; Pirrelli A; Mancini M
    J Clin Pharmacol; 1994 Sep; 34(9):919-23. PubMed ID: 7983235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New sustained-release nifedipine formulation in treatment of essential hypertension. Unidipin Cooperative Study Group.
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):349-53. PubMed ID: 1378112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-four-hour blood pressure monitoring during treatment with extended-release felodipine versus slow-release nifedipine in elderly patients with mild to moderate hypertension: a randomized, double-blind, cross-over study.
    Bonaduce D; Canonico V; Petretta M; Forgione L; Ianniciello A; Cavallaro V; Bertocchi F; Rengo F
    Eur J Clin Pharmacol; 1997; 53(2):95-100. PubMed ID: 9403278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ambulatory blood pressure profiles in essential hypertensives after treatment with a new once daily nifedipine formulation.
    Nold G; Herholz C; Sturm M; Hopf R; Lemmer B
    J Hum Hypertens; 1999 Mar; 13(3):173-7. PubMed ID: 10204813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover study.
    Anderton JL; Vallance BD; Stanley NN; Crowe PF; Mittra B; Perks WH
    Drugs; 1988; 35 Suppl 4():22-6. PubMed ID: 3288467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of once-daily nifedipine coat-core in the treatment of mild-to-moderate hypertension. Adalat CC Cooperative Study Group.
    Feig PU; Gibson L; Mac Carthy EP; Pettis PP; Schwartz L
    Clin Ther; 1993; 15(6):963-75. PubMed ID: 8111816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of once-daily monotherapy with a new nifedipine sustained release calcium antagonist.
    Carr AA; Bottini PB; Feig P; Prisant LM; Mulligan S; Devane JG; Fisher L; Rhoades RB; MacCarthy EP
    Am J Cardiol; 1992 Apr; 69(13):28E-32E. PubMed ID: 1575174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effects of a new sustained-release formulation of nifedipine.
    Zachariah PK; Schwartz GL; Sheps SG; Schirger A; Carlson CA; Moore AG
    J Clin Pharmacol; 1990 Nov; 30(11):1012-9. PubMed ID: 2243148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension.
    Kirby BJ; Kitchin NR
    Int J Clin Pract; 1999; 53(5):339-43. PubMed ID: 10695096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of blood pressure in hypertensive patients with felodipine extended release or nifedipine retard.
    Littler WA
    Br J Clin Pharmacol; 1990 Dec; 30(6):871-8. PubMed ID: 2288833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
    Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
    J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of the coadministration of carvedilol and nifedipine sustained-release in the treatment of essential hypertension.
    Juttmann JR; de Vries Robles P; Venuti RP
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S134-7. PubMed ID: 1378141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
    de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M
    Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and bioavailability of a sustained release nifedipine formulation.
    Piovella C
    Arzneimittelforschung; 1987 Jul; 37(7):832-5. PubMed ID: 3675679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and efficacy of once-daily nifedipine coat-core in combination with atenolol in hypertensive patients. Adalat CC Cooperative Study Group.
    Mac Carthy EP; Pettis PP; Gibson L; Schwartz L; Feig PU
    Clin Ther; 1993; 15(6):976-87. PubMed ID: 8111817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of nifedipine derived from a new retard tablet formulation.
    Avgerinos A; Gorrod JW
    Eur J Drug Metab Pharmacokinet; 1990; 15(4):273-8. PubMed ID: 2088764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side effects of dihydropyridine therapy: comparison of amlodipine and nifedipine retard.
    Hosie J; Bremner AD; Fell PJ; James GV; Saul PA; Taylor SH
    J Cardiovasc Pharmacol; 1993; 22 Suppl A():S9-12. PubMed ID: 7522287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension. A placebo-controlled, double-blind parallel-group trial.
    Harder S; Rietbrock S; Thürmann P
    Arzneimittelforschung; 1994 Feb; 44(2):133-6. PubMed ID: 8147945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.